VIRO-safe® THE EARLY WARNING SYSTEM FOR THE CANCER FORMATION THROUGH A HPV

VIRO-safe packs the HPV-capsid protein L 1 before the cell degrades and builds cancer.

as shown

  • VIRO-safe® HPV screening KIT (VASK) for the general screening of every HPV type (excl.1,0,63)

  • VIRO-safe® HPV screening KIT (VAHK) specific screening of high-risk-types with the High-risk-KIT (VAHK)

      Advantages of VIRO-safe® high-risk-KIT (VAHK):

    • It is possible to apply histological and cytological material
    • It is possible to apply Pap-coloured products already filed
    • The morphology of the cells persists


    Approx. 50 % of all HPV-Infects in case of light to moderate dysplasia are caused by types of high risk. In large trials with high risk types, 83 & of light to moderate HPV 16 DNS of positive dysplasia were diagnosed with VIRO-safe®.

    The capsid protein L 1 of the human Papillom virus (HPV) stimulates the human immune system. The production of virus capsid protein will be reduced significantly in heavy lesions. As a consequence of the loss of the virus capsid protein L 1 in a grave dysplasia, the human immune system losses the immune reaction.